Conference abstractPublished 5 Nov 2018
Discovery of EED inhibitor BR554: Preclinical candidate as anti-cancer therapy
Shanghai Blueray Bio-pharma Co. Ltd., China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
WD40 repeat (WDR) domain is one of the largest protein families from yeast to human, consisting about 1% total cell protein. WDR proteins generally function as platform of protein-protein interactions and are involved in a wide range of cellular processes. Embryonic Ectoderm Development (EED), a subunit of PRC2 complex, is an important member of WDR family and plays critical role of methylating H3K27. Herein, a novel class of EED inhibitors, represented by BR554, with great drug-like properties, in vivo efficacy and favorable toxicology profile.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Zou Bin”